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a b s t r a c t
An existingmodel of tumor growth that accounts for cell cycle arrest and cell death induced
by chemotherapy is extended to simulate the response to treatment of a tumor growing
in vivo. The tumor is assumed to undergo logistic growth in the absence of therapy, and
treatment is administered periodically rather than continuously. Necessary and sufficient
conditions for the global stability of the cancer-free equilibrium are derived and conditions
under which the system evolves to periodic solutions are determined.
© 2012 Elsevier Ltd. All rights reserved.
1. Introduction
In this paper, we analyze the following equation which models the response of a population of tumor cells to periodic
treatment with chemotherapy:
dN
dt
= N

1− N −
 t
t−ar
α(u)e−ρ(u) (t−u)N(u)du

− α(t)N. (1)
Eq. (2) is a non local delay differential equation where N(t) represents the number of proliferating tumor cells at time
t . For convenience, we introduce the following notation in our model. Define the functional f : R × C[−ar , 0] → R
as f (t,N(·)) =  0−ar α(t + u)e−u ρ(t+u)N(u)du, and define Nt(·) ∈ C[−ar , 0] as Nt(x) = N(t + x). It follows that t
t−ar α(u)e
−ρ(u) (t−u)N(u)du = f (t,Nt(·)), so that in the new notation Eq. (1) is rewritten as:
dN
dt
= N (1− N − f (t,Nt(·))) − α(t)N. (2)
Eq. (2) derives from amathematical model describing the response of tumor cells growing in vitro to a chemotherapeutic
drugwhich causes proliferating cells first to become growth-arrested in response to drug-induced DNA damage, and then to
die at rates which are proportional to the amount of DNA damage sustained [1]. To simulate the response to treatment of a
tumor growing in vivo, the originalmodel has beenmodified as follows. Cells are assumed to grow logistically in the absence
of treatment and chemotherapy is administered periodically, with period τ .α(t) represents the rate of cell arrest in response
to therapy application, and is a bounded, non-negative periodic function with period τ . The integral term represents the
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Fig. 1. When α¯ < 1, Eq. (2) admits a periodic solution (dashed curve) while for α¯ > 1, the eradication of tumor cells is predicted (solid curve). In both
cases, therapy is administered on a weekly schedule starting at time t = 19 days.
number of cells in the arrested state at time t . These cells are assumed to compete for space with the proliferating cells and
die at a rate ρ(t). We further suppose that cells remain in the arrested compartment for at most a time period, ar (ar < τ ).
Eq. (2) belongs to a general class of integro-differential equations, that arise naturally in population dynamics when
the past history of the species influences its current growth rate. Models of periodic chemotherapy based on the logistic
equation have been studied previously [2–4]; criterion for the elimination of the tumor have been derived, and questions
relating to the emergence of drug resistance, and the effect of treatment period on tumor reduction are studied. A common
feature of these models is the assumption that chemotherapy instantaneously stimulates cell death. In Eq. (2), we relax this
assumption by supposing that the response of tumor cells to treatment is not instantaneous, but rather acts over a finite
period of time.
In the sections that follow, we derive conditions for the global stability of the trivial solution (N(t) = 0) of Eq. (2), this
solution corresponding to a cancer-free equilibrium. Using techniques from functional analysis, we prove the existence of a
periodic solution when the cancer-free equilibrium is unstable. We conclude with a brief discussion on the relevance of our
work.
2. Analytical results
Let α¯ = (1/τ)  τ0 α(t)dt . Numerical simulations of Eq. (2) show qualitatively different behavior as α¯ is varied. When
α¯ > 1, limt→∞ N(t) = 0 (Fig. 1, solid curve) and in Section 2.1 we prove the global stability of the trivial solution N = 0
for α¯ ≥ 1. When α¯ < 1, the system evolves to a periodic solution (Fig. 1, dashed curve), whose existence is proven in
Section 2.2. We remark that Eq. (2) is stated in dimensionless terms and that we restrict attention to biologically relevant
initial conditions, that is, we assume N(t) ≥ 0 for t < 0 and 0 < N0 = N(t = 0) ≤ 1, where 1 is the carrying capacity of
Eq. (2) in the absence of treatment. The positivity of solutions of Eq. (2) follows from the observation that any solution can
be written as
N(t) = N0 exp
 t
0
{1− N(s)− f (s,Ns(·))− α(s)} ds

.
2.1. Stability of the cancer-free equilibrium
In this section, we prove that treatment will successfully eradicate the tumor iff α¯ ≥ 1.
Theorem 1. N = 0 is a global attractor for Eq. (2) iff α¯ ≥ 1.
Proof. The proof follows from Lemmas 2 and 3. 
Lemma 2. Let α¯ ≥ 1. Then, N = 0 is a globally stable fixed point of Eq. (2).
Proof. For any ζ ∈ [0, τ ], and for any integer n ≥ 1, ζ+τ
ζ
dN
N
=
 τ
0
(1 − α(t))dt −
 ζ+τ
ζ
(f (t,Nt(·)) + N)dt
⇒ N(ζ + τ) = N(ζ ) eτ(1−α¯) e−
 ζ+τ
ζ (f (t,Nt (·))+N)dt
⇒ N(ζ + nτ) = N(ζ ) En(α¯) A(ζ ) Bn(ζ ) (3)
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where En(α¯) = enτ(1−α¯), A(ζ ) = e−
 τ
ζ (f (t,Nt (·))+N)dt , and Bn(ζ ) = e−
 nτ
τ (f (t,Nt (·))+N)dt . We claim that limn→∞ N(ζ + nτ) = 0.
There are two cases to consider: α¯ > 1 and α¯ = 1.
Now, α¯ > 1 ⇒ limn→∞ En(α¯) = 0. Additionally, α(t),N(t) ≥ 0 ⇒ A(ζ ), Bn(ζ ) ≤ 1. Therefore, from Eq. (3) we obtain
limn→∞ N(ζ + nτ) = 0.
When α¯ = 1, limn→∞ En(α¯) = 1. Let limT→∞
 T
τ
(f (t,Nt(·))+ N)dt = κ , where κ > 0. Suppose now that κ <∞. Then,
it follows from Eq. (3) that limn→∞ N(ζ + nτ) = η(ζ ), where 0 < η(ζ ) = κ N(ζ ) A(ζ ) is continuous on [0, τ ] (continuity
follows from the boundedness of dN/dt). Therefore, η(ζ )must attain its minimum (say ηmin) in [0, τ ].
As A(ζ ) and Bn(ζ ) are exponentials with negative exponents, the sequences {N(ζ + nτ)}n, ζ ∈ [0, τ ] decrease
monotonically, and we deduce that N(t) ≥ ηmin∀t (otherwise, it would be possible to construct a sequence that converges
to a limit< ηmin). This contradicts our original assumption that κ is finite: if N(t) is bounded away from zero (and positive)
then limT→∞
 T
τ
(f (t,Nt(·))+ N)dt must diverge. Hence, for each ζ in [0, τ ], limn→∞ N(ζ + nτ) = 0.
We complete our proof by first introducing ϵ > 0. Since limn→∞ N(nτ) = 0, ∃nϵ > 0 such that N(nτ) < ϵe−τ∀n ≥ nϵ .
Define tϵ = nϵτ and consider any t ≥ tϵ . Then ∃n ≥ nϵ such that t = nτ + ζ , where ζ ∈ [0, τ ). Proceeding as in the first
part of this lemma,
 ζ
0 (1− α(t))dt < τ for ζ ∈ [0, τ ], and so we have
N(t) = N(nτ) exp
 ζ
0
(1− α(t))dt −
 nτ+ζ
nτ
(f (t,Nt(·))+ N(t))dt

< ϵ ∀ t ≥ tϵ .
Thus, limt→∞ N(t) = 0. 
Lemma 3. If N = 0 is a globally attracting fixed point of Eq. (2), then α¯ ≥ 1.
Proof. Suppose α¯ < 1 and choose δ > 0 such that α¯ < 1 − δ < 1. Let αm = maxt∈[0,τ ] α(t). Then, f (t,Nt(·)) ≤
αm
 t
t−ar N(u)du. Since limt→∞ N(t) = 0, given ϵ > 0, ∃tϵ > 0, such that N(t) < ϵ∀t ≥ tϵ . Choose ϵ = δ/(1+ αmar). Then,
1
N
dN
dt
= 1− N − f (t,Nt(·))− α(t)
≥

1− δ
1+ αmar −
δ
1+ αmar αmar − α(t)

, ∀ t ≥ tϵ + ar
⇒ N(t + τ)/N(t) ≥ exp {τ (1− δ − α¯)} > 1
by suitable choice of δ. We can therefore construct a sequence {N(tϵ + nτ)}n that is strictly increasing, which contradicts
the assumption that limt→∞ N(t) = 0. 
2.2. Existence of periodic solutions
Here, we prove that if a tumor is under-treated (α¯ < 1), then Eq. (2) admits an oscillatory solutionwhose periodmatches
that ofα(t).We also determine a condition for the local stability of this oscillatory solution in the extreme casewhen therapy
is administered continuously.
Theorem 4. If α¯ < 1, then ∃ a nontrivial τ -periodic solution of Eq. (2).
In order to prove this theorem, several preliminary results are required. As before, let δ > 0 such that α¯ < 1− δ < 1, and
define µ = δ/(1+ αmareαmar (1+ar ))where αm = max(α(t)). Further, N(t) ≤ 1∀t ≥ 0, since, if t1 is the first time such that
N(t1) = 1, then dN(t1)/dt ≤ N(1− N) = 0. Therefore,
1
N
dN
dt
= 1− N − f (t,Nt(·))− α(t) ≥ −f (t,Nt(·))− α(t) ≥ −αmar − αm (4)
⇒ N(t0 − t) ≤ N(t0)eαm(1+ar )t ≤ N(t0)eαm(1+ar )ar , ∀ 0 ≤ t ≤ ar . (5)
Further, if A = max{1, αmar + αm}, as N(t) ≤ 1, from Eq. (4) it follows that
− αmar − αm ≤ dNdt ≤ 1 ⇒ |N(t1)− N(t2)| ≤ A|t1 − t2|, ∀ t1, t2 > 0. (6)
Lemma 5. Let N(t) be a solution of Eq. (2) and suppose ∃t0 such that N(t0) = µ. Then N(t) ≥ θ∀t ≥ t0, where θ =
µ e−(αm+αmar )τ .
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Proof. Let N(t0) = µ. We first show that if N(t) < µ for t0 < t ≤ T , where T is the maximum possible time for which this
is true, then T ≤ t0 + τ . We proceed by contradiction. If T > t0 + τ , then Eq. (5) supplies:
1
N
dN
dt
≥ 1− µ− µαmareαm(1+ar )ar − α(t), ∀ t0 < t ≤ t0 + τ ≤ T
⇒ N(t0 + τ) ≥ N(t0)eτ (1−δ−α¯) > µ
since α¯ < 1− δ andµ+µαmareαm(1+ar )ar = δ. This contradicts the definition of T . Combining the result above with Eq. (4),
we deduce that mint∈[t0,t0+τ ] N(t) = θ , and the lemma follows. 
Weremark that the above results imply that a solutionN(t) of Eq. (2),withN(t = 0) = N0 ≥ µ, satisfiesN(t) > θ∀t ≥ 0.
Corollary 6. Consider 0 < η < µ. If N(t = 0) = N0 ≥ η, then ∃Tη(τ , η) such that N(t) ≥ θ∀t ≥ Tη .
Proof. We first show that if 0 < N0 < µ, then ∃0 < T <∞ such that N(t) < µ for t < T and N(T ) = µ. Proceeding as in
Lemma 5, N(τ ) > N0 eτ(1−δ−α¯). Similarly, ∀n ∈ Z+, N(nτ) > N0 enτ(1−δ−α¯). Define g(x) = ⌈1/(τ (1− δ− α¯)) ln(µ/x)⌉, x ∈
(0, 1], and letm0 = g(N0). Then, N0 em0τ(1−δ−α¯) > µ since, by definition, 1− δ − α¯ > 0. Thus, T ≤ m0τ .
IfN0 ≥ µ, we are done by Lemma 5. If η ≤ N0 < µ, the corresponding solutionN(t) crossesµ by time g(N0)τ . Observing
that g(x) is a decreasing function of x, we may take Tη = g(η)τ . Once again, the application of Lemma 5 completes the
proof. 
Proof of Theorem 4. The proof follows from Horn’s Fixed Point Theorem [5].
Let X0 ⊂ X1 ⊂ X2 be non-empty convex sets in a Banach space X with X0 and X2 compact and X1 open relative to X2. Let
W be a continuous mapping X → X such that, for some m ∈ Z+, W j(X1) ⊂ X2 for 1 ≤ j ≤ m − 1, and W j(X1) ⊂ X0 for
m ≤ j ≤ 2m− 1, where W j = W ◦ · · · ◦W  
j−times
. Then W has a fixed point in X0.
Let X = C[−ar , 0] be equipped with the supremum norm ∥ · ∥∞. Define:
X2 = {f ∈ X: f (0) ≥ η, 0 ≤ f (x) ≤ 1, |f (x)− f (y)| ≤ A|x− y| ∀ x, y ∈ [−ar , 0]},
X0 = {f ∈ X: θ ≤ f (x) ≤ 1, |f (x)− f (y)| ≤ A|x− y| ∀ x, y ∈ [−ar , 0]}, and
X1 = {f ∈ X2: f (0) > η}, where A = max{1, αmar + αm} as in Eq. (6), θ = µ e−(α¯+αmar )τ as in the proof of Lemma 5
and 0 < η < θ . We remark that X2 is pointwise bounded by definition, and is uniformly equicontinuous since any
f ∈ X2 satisfies a Lipschitz condition. Further, let {fn}n be a sequence in X2 converging to some limit function f in X. Then,
f (x) = limn→∞ fn(x) ∈ [0, 1], f (0) = limn→∞ fn(0) ≥ η, and |f (x)− f (y)| = limn→∞ |fn(x)− fn(y)| ≤ A|x−y|. Thus, f ∈ X2,
and X2 is closed. By the Arzelà–Ascoli Theorem [6], it follows that X2 is compact in X. Likewise, X0 is compact in X . A similar
argument shows that X2, X1 and X0 are convex subsets of X .
DefineW (Ni(t)) = N(t+τ)|[−ar ,0], whereN(t) is the solution of Eq. (2)with initial conditionNi ∈ X . Then,W j(X1) ⊂ X2∀j
and by Corollary 6, W j(X1) ⊂ X0 for j ≥ g(η). Thus, by Horn’s theorem, W has a fixed point. By uniqueness of solutions,
and observing that if N(t) is a solution of (2) then so is N(t + τ), the fixed point must correspond to a τ -periodic solution of
Eq. (2), Nper(t), say. 
We remark that if Nper(t) is any τ -periodic solution of Eq. (2), then the average total number of cells over a time period τ is
1− α¯, since ∀ time T > 0,
0 = [lnNper ]t=T+τt=T =
 T+τ
T
1
Nper
dNper
dt
=
 T+τ
T

1− Nper − f (t,Nper)− α(t)

dt
⇒ 1 − α¯ = 1
τ
 T+τ
T
(f (t,Nper)+ Nper)dt.
We finally consider the extreme case when therapy is administered continuously, that is for α(t) = α and ρ(t) = ρ,
α, ρ constant. Then, Eq. (2) admits a non-zero steady-state Np = ρ(1−α)/(ρ+α(1−γ )), where γ = e−ρar . In Theorem 7,
we prove a condition for the local stability of Np.
Theorem 7. For 0 < α < 1, 0 < ρ and 0 ≤ ar , Np is a locally stable steady state of Eq. (2) if α < 4ρe2ρar .
Proof. An application of the Linear Chain Trick [7], reduces Eq. (2) to the following system of delay differential equations,
on making the substitutionM(t) = f (t,Nt(·))/α:
dN
dt
= N (1− α − N − αM) (7)
dM
dt
= N − γN(t − ar)− ρM. (8)
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The steady states of Eqs. (7) and (8) are (0, 0) and (Np,Np(1− γ )/ρ). Linearizing Eqs. (7) and (8) about the non-zero steady
state, we obtain the following characteristic equation.
λ2 + (Np + ρ)λ+ (ρ + α)Np − αγNpe−λar = 0. (9)
When ar = 0, the roots of Eq. (9) are λ = −ρ and λ = −(1 − α), so that Np is asymptotically stable. Arguing as in [8],
since the roots of Eq. (9) vary continuously with the coefficients, in order for an instability to arise when ar > 0 some of
these roots must cross the imaginary axis. We show that this is not possible when 4ρe2ρar > α. Note that we have used the
fact that the set P = (a, b, c) ∈ R3+ : 4be2bc > a, a < 1 is a path connected subspace of R3 as the function h : R2+ → R
defined as h(b, c) = 4be2bc is monotonic in b, c.
If possible, let λ = ιy, y ∈ R be a root of Eq. (9). Then y satisfies
−y2 + (ρ + α)Np − αγNp cos(yar) = 0 (10)
(Np + ρ)y+ αγNp sin(yar) = 0. (11)
From the above equations it follows that y4 + By2 + C = 0, where B = N2p − 2αNp + ρ2 and C = (1− γ )2α2 + 2αρ + ρ2.
In particular, 4ρe2ρar > α ⇒ B2 − 4C < 0, that is y ∉ R, a contradiction. 
3. Discussion
We have analyzed an integro-differential equation that models the response of a tumor growing in vivo to periodic
exposure to a chemotherapy which causes cells first to become growth arrested and then induces cell death within a fixed
time period. Drugs that act in this manner include platinum-based compounds such as carboplatin and cisplatin that are
today the gold-standard of therapy for a number of solid tumors. We derived a simple condition for the global stability of
the cancer-free equilibrium and proved the existence of a periodic solution in the case when the cancer-free equilibrium
was unstable. These results have practical significance in terms of determining a minimum amount of drug required to
eliminate the cancer. Numerical simulations indicate that the periodic solution found in Section 2.2 is globally attracting.
However, the proof of this result remains an open problem that is currently under investigation. We are also considering
model extensions which would allow arrested cell recovery to a proliferating state.
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